Tissue-derived Ecm
Tissue-derived Ecm - Related Videos
04:16
ECM Suspension Preparation: A Technique to Obtain Homogenous Suspension from Tissue-derived Extracellular Matrix
0 Views •
2023
This video describes the preparation of a homogenized and digested extracellular matrix suspension from decellularized and lyophilized tissues. This technique helps in fabricating ECM-derived porous foams and microcarriers for use as substrates in advanced 3D cell culture models.
02:31
Extracellular Matrix-derived Foam Fabrication via Lyophilization: A Procedure to Generate Biological Scaffolds from ECM of Decellularized Tissues
0 Views •
2023
This video describes the method for synthesizing pure ECM-derived foams without the need for chemical crosslinking. These ECM-derived foams find applications as advanced 3D in vitro cell culture models or as pro-regenerative bioscaffolds.
11:32
Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering
0 Views •
Cited by 14 •
2010
Methods for preparing an injectable matrix gel from decellularized tissue and injecting it into rat myocardium in vivo are described.
11:19
Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms
0 Views •
Cited by 26 •
2017
The tissue-specific extracellular matrix (ECM) is a key mediator of cell function. This article describes methods for synthesizing pure ECM-derived foams and microcarriers that are stable in culture without the need for chemical crosslinking for applications in advanced 3D in vitro cell culture models or as pro-regenerative bioscaffolds.
16:33
ECM Protein Nanofibers and Nanostructures Engineered Using Surface-initiated Assembly
0 Views •
Cited by 17 •
2014
A method to obtain nanofibers and complex nanostructures from single or multiple extracellular matrix proteins is described. This method uses protein-surface interactions to create free-standing protein-based materials with tunable composition and architecture for use in a variety of tissue engineering and biotechnology applications.
FAQs
Matrix architecture, molecular composition, and biochemical cues can each shape how cancer cells adhere, migrate, proliferate, and signal. Preserving these features matters because they provide more than physical support: they reproduce tissue-associated information that cells encounter within a tumor environment. Examining these matrix properties helps researchers connect specific microenvironmental conditions with changes in cancer cell behavior.
Decellularization removes cellular material while retaining the matrix architecture, composition, and biochemical signals that make the tissue relevant to modeling. This separation allows investigators to study how the surrounding scaffold influences cancer cells without the original tissue cells dominating the experimental system. The resulting material can therefore help isolate matrix-related contributions to adhesion, migration, proliferation, and signaling.
Matrix features from different tissues may provide distinct biochemical and structural contexts, helping researchers investigate why cancer behavior varies across microenvironments. Tissue-derived ECM can be used to examine how surrounding stroma contributes to invasion and metastasis, and whether those matrix conditions alter therapeutic response. This supports disease models that connect local tissue context with progression-related outcomes.
Researchers begin with biological tissue, remove its cellular material through decellularization, and retain the remaining matrix architecture and composition. They then incorporate the matrix into three-dimensional cultures or organoid systems, where cancer cells can interact with a more tissue-relevant scaffold. These models support examination of adhesion, migration, proliferation, signaling, invasion, metastasis, and responses to treatment.
They are useful when a study needs to examine cancer cells within a structured, tissue-relevant environment rather than only assessing behavior in a simplified setting. Tissue-derived ECM can recreate aspects of the tumor microenvironment, allowing investigators to study interactions between cancer cells and surrounding stroma. This is particularly relevant for analyzing invasion, metastasis, and matrix-dependent signaling in three dimensions.
Adding tissue-derived matrix to three-dimensional cultures or organoids can make drug-testing systems more physiologically relevant. Because the matrix retains tissue-associated architecture, composition, and biochemical cues, it may reveal how the microenvironment influences therapeutic response. Researchers can therefore compare treatment outcomes under different tissue contexts and investigate why responses in simplified models may differ from those supported by tumor-associated conditions.